Darmiyan
YC S17San Francisco, US · Founded 2016 · Delaware corporation · 8 employees · 14 known investors
Find your way into Darmiyan
Sign up to see every warm intro you have to Darmiyan
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Darmiyan team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Darmiyan develops brain-analysis technology for early detection of Alzheimer's disease. Its first product, BrainSee, aims to identify the disease at an early stage.
Founders & leadership· Y Combinator alumni (S17)
Darmiyan was founded in 2016 by Padideh Kamali-Zare and Kaveh Vejdani.

Board
Investors · 14
How we know: AAF Management Ltd.'s portfolio page · Y Combinator's founder network · Not right? Tell us
How we know: prnewswire.com · Y Combinator's founder network · Not right? Tell us
How we know: IT-Farm Corporation's portfolio page · Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · somacap.com · Not right? Tell us
How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: Y Combinator's founder network · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$10M disclosed across 2 rounds · 2020–2023
▶$3.5MraisedOct 2023 · 5 investors · Other TechnologyRule 506(b)
- Kaveh VejdaniDirector
- Takehiro ShiraiDirector
- Padideh Kamali-ZareExecutive Officer
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.4MraisedApr 2020 · 32 investors · BiotechnologyRule 506(b)
- Padideh Kamali-ZareExecutive Officer, Director
- Shirai TakehiroDirector
- Kaveh VejdaniExecutive Officer, Director
- Offering amount
- $9.7M
- Amount sold
- $6.4M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Companies working in the same space as Darmiyan.
Legal entities · 1
corporate structureIn the news
Frequently asked questions
- What does Darmiyan do?
- Darmiyan develops brain-analysis technology for early detection of Alzheimer's disease. Its first product, BrainSee, aims to identify the disease at an early stage.
- Who founded Darmiyan?
- Darmiyan was founded by Padideh Kamali-Zare, Kaveh Vejdani in 2016.
- Who are Darmiyan's investors?
- Darmiyan's investors include AAF Management Ltd., Eisai Innovation, Inc., IT-Farm Corporation, Soma Capital, Y Combinator, Arkitekt Ventures, Baleen Capital, DHVC and 6 more.
- How much funding has Darmiyan raised?
- Darmiyan has disclosed $10M raised across 2 rounds.
- Where is Darmiyan headquartered?
- Darmiyan is headquartered in San Francisco, US.











